# Persistent Lyme Empiric Antibiotic Study Europe

> **NCT01207739** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 280 (actual)

## Conditions studied

- Lyme Disease
- Borrelia Infection

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Clarithromycin and hydroxychloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01207739
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-10
- **Final completion:** 2014-10
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2016-09-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207739, "Persistent Lyme Empiric Antibiotic Study Europe". Retrieved via MORVS 2026-11-01 from https://api.morvs.ai/clinical/NCT01207739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*